US › Healthcare

Akanda Corp (AKAN)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$5.16-4.27%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$258,075

Revenue YoY

-66.2%

Net profit

$-44.8M

Profit YoY

-69.6%

EPS

$-2.02

EPS estimate

$0.00

Net margin

-17,342.7%

Key statistics

Market cap

$2.9M

Forward P/E

0.0

P/B

2.21

Book value

$-15.59

EPS (TTM)

$-15,320.90

52-week high

$118.45

52-week low

$2.30

50-day MA

$13.78

200-day MA

$15.54

Beta

14.23

Shareholding

Insiders

0.59%

Institutions

1.21%

Largest institutional holders

Fund	Stake
SBI Securities Co Ltd	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Akanda Corp — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.